Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome
Blood Res
.
2013 Mar;48(1):68-9.
doi: 10.5045/br.2013.48.1.68.
Author
Chul Won Jung
1
Affiliation
1
Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
PMID:
23589801
PMCID:
PMC3625002
DOI:
10.5045/br.2013.48.1.68
No abstract available